Author

Emanuela Ferraro

European Institute of OncologyORCID 0000-0001-5863-2391Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:benchmark study· 1 Research Focus:benchmarking· 1 Research Focus:differential expression· 1 Assay:GWAS summary statistics· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Antonio MarraiD· 2 shared Andrea M. GazzoiD· 1 shared Anton Mikhailovich SafonoviD· 1 shared Ben O’LearyiD· 1 shared Bob T. LiiD· 1 shared Bradley Stephen WubbenhorstiD· 1 shared Chaitanya BandlamudiiD· 1 shared Dara S. RossiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Antonio MarraORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsGenome biologyPeer-reviewedAug 22, 2026

Benchmarking generative AI tools for literature retrieval and summarization in genomic variant interpretation.

Andrea M. Gazzo, Silvia Berardelli, Matteo Biancospino…·Paolo Magni

This study benchmarks generative AI tools for summarizing genomic variant literature, finding VarChat and Gpt-4o perform best with expert validation needed for reliability.

DOI 10.1186/s13059-026-04237-1

humanGWAS summary statistics

𝕏 PostBluesky

GenomicsbioRxivPreprintFeb 5, 2024

Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancer

Anton Mikhailovich Safonov, Antonio Marra, Chaitanya Bandlamudi…·Pedram Razavi

The paper identifies how germline and somatic mutations interact to cause resistance to CDK4/6 inhibitors in breast cancer and proposes a sequential treatment strategy using PARP inhibitors.

18 citations

humanwhole-exome sequencing

𝕏 PostBluesky